InMed Pharmaceuticals and Alzheimer’s Research | Trade to Black [Video]

Join our Trade to Black Podcast with InMed Pharmaceuticals (NASDAQ: INM) CEO Eric Adams to learn how the company is pioneering Alzheimer’s treatment with innovative cannabinoid analogs. InMed focuses on cannabinoid analogs to treat Alzheimer’s, targeting multiple brain pathways for enhanced efficacy. InMed Pharmaceuticals is at the forefront of Alzheimer’s research, offering hope to millions and presenting a promising investment opportunity.

Join TDR Co-Host Shadd Dales and Anthony Varrell as they discuss the potential and challenges in Alzheimer’s research and how InMed Pharmaceuticals is positioned.
#InMedPharmaceuticals #alzheimerresearch #smallcapstocks #cannbinoids

Want to watch more videos about InMed?
https://youtu.be/d6aYevOxTWI?si=AqifrzAqN27GbzcK
https://youtu.be/3VmMQqlRg3Y?si=fJFGsxTrEHdBbRuI
https://youtu.be/Gnedd79ugY0?si=NKcH2C9moSfdUivW

Want to be updated on all things Psychedelic, Cannabis, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com/subscribe

Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook: https://www.facebook.com/TheDalesReport
Twitter: https://twitter.com/TheDalesReport
Instagram: https://www.instagram.com/dalesreport
Website: https://thedalesreport.com/

For copyright matters, please get in touch with us at:
[email protected]

Disclaimer:
https://thedalesreport.com/disclosure/inmed-pharmaceuticals-inc/